Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.17 USD | -4.81% | -7.50% | -24.93% |
Apr. 23 | Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission | MT |
Apr. 22 | Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer | MT |
Business Summary
Number of employees: 1,800
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Cell Therapies
100.0
%
| 117 | 100.0 % | 285 | 100.0 % | +143.70% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
94.7
%
| 117 | 99.7 % | 270 | 94.7 % | +131.47% |
Europe
5.3
%
| 0 | 0.1 % | 15 | 5.3 % | +19,993.33% |
China
0.1
%
| 0 | 0.3 % | 0 | 0.1 % | -45.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ying Huang
CEO | Chief Executive Officer | 51 | 19-06-30 |
Lori Macomber
DFI | Director of Finance/CFO | 53 | 19-08-31 |
Tracy Luo
CTO | Chief Tech/Sci/R&D Officer | - | 18-04-30 |
Liz Gosen
CTO | Chief Tech/Sci/R&D Officer | - | 19-04-30 |
Guowei Fang
CTO | Chief Tech/Sci/R&D Officer | - | 22-02-28 |
Mythili Koneru
CTO | Chief Tech/Sci/R&D Officer | 46 | 23-04-10 |
- | - | ||
Jessie Yeung
IRC | Investor Relations Contact | - | 18-12-31 |
Elaine Qian
HRO | Human Resources Officer | - | 19-10-31 |
Yuhong Qiu
LAW | General Counsel | - | 18-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ying Huang
CEO | Chief Executive Officer | 51 | 19-06-30 |
Corazon Sanders
BRD | Director/Board Member | 67 | 20-04-30 |
Li Zhu
BRD | Director/Board Member | 74 | 20-11-22 |
Patrick J. Casey
BRD | Director/Board Member | 68 | 20-12-02 |
Fang Liang Zhang
CEO | Chief Executive Officer | 59 | 15-05-26 |
Tomas Jan Heyman
BRD | Director/Board Member | 68 | 22-08-01 |
Ye Wang
BRD | Director/Board Member | 55 | 15-04-30 |
Wai Man Yau
BRD | Director/Board Member | 48 | 20-04-30 |
Xiao Hui Ji
BRD | Director/Board Member | 62 | 20-04-30 |
Li Mao
BRD | Director/Board Member | 67 | 22-08-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 363,822,069 | 360,183,848 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.93% | 8.22B | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.78% | 22.2B | |
-16.53% | 21.23B | |
-9.14% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- LEGN Stock
- Company Legend Biotech Corporation